Translation element EIF4A1 is a potential divergent immune biomarker between colon cancer and rectal cancer
The heterogeneity of EIF4A1 and its differential roles in driving cancer progression between colon and rectal cancers highlight the need for subtype-specific immunotherapeutic strategies for these malignancies.
Authors
- Zhenpeng Zhu (ORCID: https://orcid.org/0009-0000-4089-3374)
- Xiran Wang (ORCID: https://orcid.org/0000-0001-5466-0192)
- Weizheng Liang (ORCID: https://orcid.org/0000-0001-9244-6875)
- Peng Wang (ORCID: https://orcid.org/0009-0002-1009-6416)
- Dandan Xu (ORCID: https://orcid.org/0000-0003-1540-5767)
- Fei Guo (ORCID: https://orcid.org/0000-0003-4856-6751)
- Shan Liu
- Xuejun Zhi (ORCID: https://orcid.org/0009-0009-1907-0352)
- Jiajia Xiao (ORCID: https://orcid.org/0009-0002-2521-5713)
- Flora Yan (ORCID: https://orcid.org/0000-0003-4775-0784)
- Jun Xue
- C. Hou (ORCID: https://orcid.org/0009-0008-4004-5613)
Institutions
- Hebei Medical University (CN)
- Hebei North University (CN)
- Bio-Medical Science (South Korea) (KR)
- Changchun University (CN)
Publication Details
- Journal
- International Journal of Immunopathology and Pharmacology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1177/03946320251379175
- Primary Topic
- PI3K/AKT/mTOR signaling in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00